Related references
Note: Only part of the references are listed.Alemtuzumab in Combination With Methylprednisolone Is a Highly Effective Induction Regimen for Patients With Chronic Lymphocytic Leukemia and Deletion of TP53: Final Results of the National Cancer Research Institute CLL206 Trial
Andrew R. Pettitt et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Guidelines on the use of irradiated blood components prepared by the British Committee for Standards in Haematology blood transfusion task force
Jennie Treleaven et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Kidney Transplantation With Minimized Maintenance: Alemtuzumab Induction With Tacrolimus Monotherapy-An Open Label, Randomized Trial
Kakit Chan et al.
TRANSPLANTATION (2011)
Consolidation Therapy With Subcutaneous Alemtuzumab After Fludarabine and Rituximab Induction Therapy for Previously Untreated Chronic Lymphocytic Leukemia: Final Analysis of CALGB 10101
Thomas S. Lin et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Transfusion-associated graft-versus-host disease
D. M. Dwyre et al.
VOX SANGUINIS (2008)
Early diagnosis and successful treatment of a patient with transfusion-associated GVHD with autologous peripheral blood progenitor cell transplantation
K Hutchinson et al.
TRANSFUSION (2002)
Transfusion-associated graft-versus-host disease
ML Schroeder
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Share Paper
